Latest Breaking News On - Sijmen de vries - Page 1 : comparemela.com

Pharming N : Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union - Form 6-K

Pharming N : Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union - Form 6-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomNoord hollandUnited statesCity ofSouth koreaChristina renfroeMichael levitanLifespring life sciences communicationPharming groupnvVp investor relations corporate communicationsCommission file numberExchange commissionPharming groupCommittee for medicinal products human useAd hoc expert groupSecurities exchange

Pharming Group reports first quarter 2024 financial results and provides business update

Pharming Group reports first quarter 2024 financial results and provides business update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Noord hollandCity ofUnited kingdomUnited statesMichael levitanFoster mitchell alex shawAsia pacificRegulatory agencyExchange commissionInternational recognition procedureCompany euronext amsterdamKyowa kirin coLifespring life sciences communicationIsraeli ministry of healthOrchard therapeutics plcCompany the

Pharming Group N V : Pharming Group reports first quarter 2024 financial results and provides business update

Pharming Group N V : Pharming Group reports first quarter 2024 financial results and provides business update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNoord hollandCity ofAsia pacificExperte carsten storkZwei rohstoff chancenFoster mitchell alex shawMichael levitanExchange commissionKamada ltdPharming groupnvEuropean medicines agencyCompany theVp investor relations corporate communicationsAccess program

Pharming N : Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 - Form 6-K

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 .

United statesSouth africaCity ofUnited kingdomNoord hollandAmerican samoaMichael levitanVan lanschot kempenLifespring life sciences communicationCompany theCommission file numberExchange commissionPharming groupCompany euronext amsterdamVp investor relations corporate communicationsFrankfurt stock exchange

Pharming N : to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards - Form 6-K

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 .

Noord hollandUnited statesUnited kingdomCity ofChristina renfroeStephen toorMichael levitanPeter saltonstallDrug administrationIndustry innovator at nationalExchange commissionOrganization for rare disordersCommission file numberSecurities exchangePharming groupPharming groupnv